Baby Safety / Compounds / F-53B (6:2 chlorinated polyfluorinated ether sulfonate)

Is F-53B (6:2 chlorinated polyfluorinated ether sulfonate) safe for babies and kids?

Severe risk for kids

Infants accumulate F-53B (6:2 chlorinated polyfluorinated ether sulfonate) through breast milk (bioconcentration), placental transfer, and dust ingestion. Persistent pollutants concentrate in fatty tissues with extended half-lives in developing organisms.

What is f-53b (6:2 chlorinated polyfluorinated ether sulfonate)?

The IUPAC name is potassium 2-(6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexoxy)-1,1,2,2-tetrafluoroethanesulfonate.

Also known as: 73606-19-6, Potassium 9-chlorohexadecafluoro-3-oxanonane-1-sulfonate, DTXSID60881236, 9ClPF3ONS.

IUPAC name
potassium 2-(6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexoxy)-1,1,2,2-tetrafluoroethanesulfonate
CAS number
73606-19-6
Molecular formula
C8ClF16KO4S
Molecular weight
570.67 g/mol
SMILES
C(C(C(C(F)(F)Cl)(F)F)(F)F)(C(C(OC(C(F)(F)S(=O)(=O)[O-])(F)F)(F)F)(F)F)(F)F.[K+]
PubChem CID
25210512

Risk for babies

Severe risk

Infants accumulate F-53B (6:2 chlorinated polyfluorinated ether sulfonate) through breast milk (bioconcentration), placental transfer, and dust ingestion. Persistent pollutants concentrate in fatty tissues with extended half-lives in developing organisms.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Very high risk

F-53B (6:2 chlorinated polyfluorinated ether sulfonate) persists in maternal adipose tissue and is mobilized during pregnancy and lactation. Lipophilic pollutants concentrate in breast milk and cross the placenta during critical developmental windows.

Suspected reproductive toxicant (GHS H361) or suspected endocrine disruptor. Precautionary approach warranted. Animal studies or limited human data suggest developmental toxicity potential.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified F-53B (6:2 chlorinated polyfluorinated ether sulfonate). The classifications differ — that's the data.

AgencyYearClassificationNotes
ECHA——
Stockholm Convention——Nominated for listing as a POP

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter f-53b (6:2 chlorinated polyfluorinated ether sulfonate)

  • Chrome Plating — Industrial chrome plating baths, Decorative chrome plating
    Primary use — replaces PFOS as mist suppressant in chrome plating in China
  • Drinking Water — Chinese municipal water near chrome plating districts
    Detected at ng/L levels in Chinese drinking water
  • Human Biomonitoring — Chinese general population serum, Chrome plating workers
    Detected in >80% of Chinese blood samples. Also detected in US, Canadian, European samples at lower levels.

Safer alternatives

Lower-risk approaches that achieve a similar outcome to F-53B (6:2 chlorinated polyfluorinated ether sulfonate):

  • Non-fluorinated mist suppressants
    Trade-offs: Available for chrome plating. Performance gap in hard chrome applications. Adequate for decorative chrome. Lower cost per unit but higher consumption rate.
    Relative cost: 1.2-2×
  • Trivalent chromium plating
    Trade-offs: Eliminates need for hexavalent chrome mist suppressant entirely. Different appearance (slightly blue vs bright). Less corrosion resistance. Growing adoption for automotive trim.
    Relative cost: 1.2-2×
  • PFAS-free firefighting foams (fluorine-free foams / F3)
    Trade-offs: For AFFF replacement use case. Pass UL 162 at higher application rates. Require foam system re-engineering. Higher concentrate cost. No persistent fluorinated residues.
    Relative cost: Lower (ingredient elimination)

Frequently asked questions

Is f-53b (6:2 chlorinated polyfluorinated ether sulfonate) safe for kids?

Infants accumulate F-53B (6:2 chlorinated polyfluorinated ether sulfonate) through breast milk (bioconcentration), placental transfer, and dust ingestion. Persistent pollutants concentrate in fatty tissues with extended half-lives in developing organisms.

What products contain f-53b (6:2 chlorinated polyfluorinated ether sulfonate)?

F-53B (6:2 chlorinated polyfluorinated ether sulfonate) appears in: Industrial chrome plating baths (chrome plating); Decorative chrome plating (chrome plating); Chinese municipal water near chrome plating districts (drinking water); Chinese general population serum (human biomonitoring); Chrome plating workers (human biomonitoring).

What should I do if my child is exposed to f-53b (6:2 chlorinated polyfluorinated ether sulfonate)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See F-53B (6:2 chlorinated polyfluorinated ether sulfonate) in the baby app

Look up products containing f-53b (6:2 chlorinated polyfluorinated ether sulfonate), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. — expert_curation

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →